Quartesian Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-05-2024
- Paid Up Capital ₹ 0.35 M
as on 09-05-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2019
- Revenue 21.66%
(FY 2019)
- Profit 9.57%
(FY 2019)
- Ebitda 21.00%
(FY 2019)
- Net Worth 45.93%
(FY 2019)
- Total Assets 27.40%
(FY 2019)
About Quartesian Clinical Research
- CIN/LLPIN
U73100KA2004PTC034625
- Company No.
034625
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2004
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Quartesian Clinical Research?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vladimir Mats  | Director | 22-Dec-2007 | Current |
| Soumitra Shankar | Director | 02-Sep-2004 | Current |
| John Xavier | Director | 02-Sep-2004 | Current |
Thiyagarajan Ramasamy  | Director | 20-Nov-2014 | Current |
| Benjamin Francis | Director | 22-Dec-2007 | Current |
Financial Performance of Quartesian Clinical Research.
Quartesian Clinical Research Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 21.66% increase. The company also saw a slight improvement in profitability, with a 9.57% increase in profit. The company's net worth Soared by an impressive increase of 45.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quartesian Clinical Research?
In 2018, Quartesian Clinical Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Veranex India Private LimitedActive 6 years 4 monthsThiyagarajan Ramasamy and Vladimir Mats are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Quartesian Clinical Research?
Quartesian Clinical Research has a workforce of 231 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quartesian Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quartesian Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
